Chromosome 7q21-22 and multiple sclerosis: Evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene

Journal of Neuroimmunology

Volumn 125, Issue 1-2, 2002, Pages 141-148

  Vandenbroeck, Koen ^a,b   Fiten, Pierre ^a   Heggarty, Shirley ^b   Goris, An ^a   Cocco, Eleonora ^b   Hawkins, Stanley A ^d   Graham, Colin A ^b   Marrosu, Maria G ^c   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Linkage disequilibrium; Multiple sclerosis; Plasminogen activator inhibitor 1; Substance P; Tachykinin; Thymosin

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTACHYKININ 1; TACHYKININ DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CHROMOSOME 22; CHROMOSOME 7Q; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE MAPPING; GENETIC DISORDER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; START CODON;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; FAMILY HEALTH; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HUMANS; IRELAND; ITALY; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; MULTIPLE SCLEROSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROTEIN PRECURSORS; SUBSTANCE P; TACHYKININS; THYMOSIN; UBIQUITINS;

EID: 0036226405     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00023-1     Document Type: Article

References (40)

1. Plasminogen activation in multiple sclerosis and other neurological disorders
2. Clustering of non-major histocompatibility complex susceptibility loci in human autoimmune diseases
3. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen
4. Human thymosin-β4/6-26 is part of a multigene family composed of seven members located on seven different chromosome regions
5. Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and continental Italian families
6. A genome-wide search for quantitative trait loci underlying asthma
7. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI1) gene respond differently to interleukin-1 in HepG2 cells
8. T-cell receptor α, β, γ and δ chain gene microsatellites show no association with multiple sclerosis
9. Genetics of multiple sclerosis
10. A full genome search in multiple sclerosis
11. Genetic predisposition to multiple sclerosis as revealed by immunoprinting
12. Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations
13. The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-κB
14. Large-scale sequencing of two regions in human chromosome 7q22: Analysis of 650 kb of genomic sequence around EPO and CUTL1 loci reveals 17 genes
15. A complete genome screen for multiple sclerosis underscores a role for the major histocompatibility complex
16. Gametic disequilibrium measures: Proceed with caution
17. Evaluation of fine mapping strategies for a mutlifactorial disease locus: Systematic linkage and association analysis of IDDM1 in the HLA region on chromosome 6p21
18. No association with germline T cell receptor β-chain alleles or haplotypes in Swedish patients with multiple sclerosis
19. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TCR β locus: Use of affected family-based controls
20. A note on power approximations for the transmission disequilibrium test
21. The neuropeptide substance P activates transcription factor NF-κB and κB-dependent gene expression in human astrocytoma cells
22. Plasminogen activator inhibitor 1 gene and risk of MS in women
23. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles
24. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis
25. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21
26. Small actin-binding proteins: The β-thymosin family
27. Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13
28. Multiple sclerosis: Genomic rewards
29. Functional characterization of substance P receptors on cultured human spinal chord astrocytes: Synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin-E2 production
30. A meta-analysis of genomic screens in multiple sclerosis
31. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
32. Two-stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
33. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q21
34. The genetic analysis of multiple sclerosis
35. A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex
36. The TDT and other family-based tests for linkage disequilibrium and association
37. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
38. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: Effect on course and onset of disease
39. Human T-cell receptor Vβ gene polymorphism and multiple sclerosis
40. Thymosin β 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids